Johnson & Johnson rare blood clot concerns deal new blow to global vaccination drive

Reports that the Johnson & Johnson Covid-19 vaccine may, in extremely rare cases, cause blood clots has dealt a fresh blow to the world's vaccination drive, just weeks after similar concerns were raised over the vaccine developed by AstraZeneca and Oxford University.